TrialThe Journal of infectious diseases2024

Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.

Christy A Comeaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.